Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.bul.NO (nitric oxide) through a radical reaction
Takaaki Akaike(Tohoku University), Hiroshi Maeda(Kumamoto University), Yoichi Miyamoto(Kumamoto University), Masaki Yoshida(Kumamoto University), Kiminori Miyazaki, Shoichi Ueda(Kumamoto University), Kazumi Sasamoto, Keizo Sato(Kyushu University of Medical Science), Masahiro Kohno(Shibaura Institute of Technology)
Cited by 577
Related Papers
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
|PubMed|1986|6.8k
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
|Journal of Controlled Release|2000|6.5k
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
|Advanced Drug Delivery Reviews|2010|3.5k
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
|Advances in Enzyme Regulation|2001|2.5k
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
|Advanced Drug Delivery Reviews|2012|2.3k